Maximus FY26 diluted EPS jumps 32% to $7.27
MMS•Maximus’ FY26 diluted EPS rose 32% to $7.27, while revenue fell to $5.23 billion. The company forecast FY27 diluted EPS of $6.15-$6.65 and revenue of $5.45 billion-$5.65 billion.
1. FY26 results and outlook
Maximus’ FY26 diluted EPS climbed 32% to $7.27, while revenue fell to $5.23 billion. FY25 revenue benefited from elevated disaster support and temporary clinical volume surges. The Agile Defense acquisition closed, accelerating the company’s defense strategy and reducing customer concentration. For FY27, Maximus projects diluted EPS of $6.15-$6.65 and revenue of $5.45 billion-$5.65 billion.




